Biomarker Lens

Common biomarkers

  • Hemoglobin
  • Glucose
  • ALT
  • Apolipoprotein B
  • C-Reactive Protein, Cardiac
  • Ferritin
  • Alb/Creat Ratio, Urine
  • Alkaline Phosphatase
  • FSH
  • T4,Free(Direct)

Biomarkers · Chemical

Cardio IQ Apolipoprotein B

Also listed as
total calcium, Cardio IQ® Apolipoprotein B, serum calcium, ca, Cardio IQ® Apolipoprotein B
LOINC codes
13457-7, 17782-4, 1884-6, 2085-9, 2093-3, 2571-8, 30522-7, 43396-1, 43583-4, 43727-7, 43729-3, 47213-4, 54434-6, 86222-7, 86951-1, 9830-1, 1986-9, 4548-4, 89324-8, 92845-7
Tests that measure Cardio IQ Apolipoprotein B
Quest Diagnostics 3

Tests

Check the catalog code, specimen, method and preparation for every test that measures Cardio IQ Apolipoprotein B. Select up to five tests to compare them side by side.

Quest Diagnostics 3 tests

Panels that include this biomarker

  • Advanced Lipid Panel, Cardio IQ® 92145

    8 analytes · Serum · Fasting not stated

    Method and collection
    Method
    Enzymatic • Nephelometry • Immunoturbidometric • Ion Mobility • Spectrophotometry (SP)
    Preparation
    If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
    Reference notes
    See Laboratory Report
    Quest Diagnostics catalog page

  • Advanced Lipid Panel with Inflammation, Cardio IQ® 94220

    10 analytes · Serum · Fasting not stated

    Method and collection
    Method
    Enzymatic • Immunoassay (IA) • Immunoturbidimetric Assay • Ion Mobility • Nephelometry • Spectrophotometry (SP)
    Preparation
    If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
    Collection
    The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been...determined to interfere with assays for...Cholesterol, Uric Acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hr, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs.
    Reference notes
    See Laboratory Report
    Quest Diagnostics catalog page

  • Metabolic Risk Panel 39447

    11 analytes · Serum · Fasting not stated

    Method and collection
    Method
    Spectrophotometry (SP) • Enzymatic • Immunoassay (IA) • Immunocapture • Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)
    Preparation
    If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
    Reference notes
    See Laboratory Report
    Quest Diagnostics catalog page

0 of 5 tests selected

Pick one more

Sources

Verify these ranges and sources

We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.

Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.